Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In Utero HSCT for Alpha Thalassemia Major
NCT02986698Phase 1Terminated
- Sponsor
- University of California, San Francisco
- Start
- Oct 2017
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Alpha thalassemia major, sponsored by University of California, San Francisco. Primary endpoints: Maternal participant tolerance of bone marrow harvest and Safety of in utero hematopoietic stem cell transplantation. Started Oct 2017; status: terminated.
02
Conditions
Alpha thalassemia major
Beyond the preview
Go deeper on NCT02986698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02986698.